Recent Headlines
Within Pharmaceuticals
Hemanext Inc. Announces First Patients Treated in a Clinical Trial Investigating the Efficacy of the Hemanext ONE® Red Blood Cell Processing and Storage System
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces that the first two patients enrolled have begun receiving transfusions in a multi-center, randomized, controlled cross-over study to evaluate the safety and effectiveness of hypoxic red blood... - December 20, 2024 - Hemanext
Elait Health Appoints Michael Boggs as New CEO to Drive Company Strategy and Adoption of Its AI-powered Health Data Management Platform
Michael Boggs brings decades of leadership experience to drive Elait Health’s strategy, expand its AI-powered health data management platform, and enhance healthcare innovation. - December 19, 2024 - Elait Health
Exquiste Estate in the Hills Above St. Helena Hits the Market
Mayacama Luxury Real Estate is proud to present a truly remarkable property: 2509 Madrona Avenue, a sophisticated estate situated in the heart of Napa Valley's wine country. This stunning residence offers the perfect blend of timeless elegance, modern luxury, and unparalleled access to the best of... - December 17, 2024 - Mayacama Luxury Real Estate
Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024 - ALS Therapy Development Institute
Regenexx Announces Dr. Philippe Hernigou as New Medical Director of Clinical Research
Regenexx®, a leader in regenerative medicine and advanced orthobiologics, is proud to announce that Dr. Philippe Hernigou, a globally recognized expert in autologous cell therapy and musculoskeletal regeneration, has joined the company as its new Medical Director of Clinical Research. Dr. - December 11, 2024 - Regenexx
SeroRepair Announces New Office Location to Support Expansion and Growth
SeroRepair, an eye serum leader in the veterinary industry announces expansion to a new office location for increased operations, customer service, and product development, positioning the company for continued success in the veterinary industry. With an ever-growing demand for high-quality eye care products for small and large animals and a need for increasing efficiency in veterinary practices, SeroRepair has experienced significant growth over the past year. - December 10, 2024 - SeroRepair
Arizona Pharmacy Association Appoints Garet Turner as New CEO
Today, the Arizona Pharmacy Association (AzPA), the leading voice for Arizona’s pharmacy professionals, announced the appointment of Garet Turner as its new Chief Executive Officer. Turner, a seasoned management, membership and fundraising professional will take the helm on January... - December 07, 2024 - Arizona Pharmacy Association
Activate Brain and Body to Open New Location in Indianapolis Metro area
Join Activate Brain & Body Fitness on December 5 to celebrate the grand opening of theinnovative brain gym in Fishers, IN, designed to connect physical exercise with cognitive health. The event runs from 9 AM to 7 PM, with a ribbon cutting at 9 AM. Explore dual-task exercises, enjoy refreshments, and take advantage of special pre-sale offers on training programs. Activate is redefining fitness with a focus on brain health, and this event is free and open to the public. - December 04, 2024 - Activate Brain and Body Fitness
NuSirt Health Launches LEUSIX™ Natural GLP-1 Companion Supplement on Amazon
NuSirt Health has launched its innovative dietary supplement, LEUSIX™, for weight management and cardiometabolic health on Amazon.com. - November 26, 2024 - NuSirt Sciences, Inc.
BRSi, LP Promotes Natalie Van Baale to Vice President, Chief Operating Officer
BRSi, LP proudly announces Natalie Van Baale's promotion to Vice President and COO, effective November 1, 2024. With nearly two decades at BRSi, Natalie has led Federal Operations, expanding the company’s military healthcare presence and fostering key partnerships. BRSi is a leader in healthcare revenue cycle management and software development, serving military, federal, and public healthcare providers. This promotion highlights BRSi’s dedication to leadership and client success. - November 24, 2024 - BRSi
HealthPub Publishes Comprehensive FODMAP Statistics Report
Research highlights that up to 86% of IBS sufferers experience significant symptom relief by following a low-FODMAP diet, emphasizing its effectiveness in managing bloating, abdominal pain, and irregular bowel movements. - November 23, 2024 - Healthpub
CCT Sciences Announces Partnerships with Industry Leading Federally Compliant Delta-8 Producers
In September, CCT Sciences, LLC., a global leader in cannabinoid sciences, started patent enforcement across the nation with a focus on Florida. The company persists in its efforts to help the hemp cannabinoid industry regulate itself by fostering new relationships. Through partnerships with many... - November 18, 2024 - CCT Sciences
New Audio Narration for the GMP Training
Pharma Lessons has updated another course from their portfolio with voice-over functionality. The popular Good Manufacturing Practice training now features audio narration. The updated package was again developed with the same team of professionals used for the voice-over of their GCP training. A... - November 12, 2024 - Pharma Lessons
smartDOC: Automated Content Management Now with GenAI
smartDOC – Intelligent Content Platform for Knowledge Organizations. Easily manage regulatory content with streamlined process, leverage automation and deliver faster with their enterprise document / content system. - November 11, 2024 - DDi LLC
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research - November 09, 2024 - NeuroDex
NanoCellect Biomedical Announces Strategic Partnership with Additional Distributors Across the APAC Region
NanoCellect Biomedical, a leading provider of innovative microfluidic flow cytometry solutions, is excited to announce new strategic partnerships with additional distributors in the Asia-Pacific (APAC) region. These partnerships will further expand NanoCellect’s presence in these key markets,... - November 08, 2024 - NanoCellect Biomedical
Creative Biolabs Shines at the 2024 NIH Research Festival: Showcasing Antibody Solutions
Creative Biolabs made a splash at the 2024 NIH Research Festival, held from Sept. 23–25, as they highlighted their groundbreaking work in antibody discovery and development. - November 08, 2024 - Creative Biolabs
Life's Transformations: The Yellow Butterfly's Lupus Experience
Rosemarie K. Witter Foundation (RKW), a not-for-profit organization dedicated to promoting medical research in finding effective treatment, leading to a cure for Lupus, is thrilled to announce the upcoming original performance of The Yellow Butterfly: A Lupus Story Benefit Play. This event aims to... - November 06, 2024 - Rosemarie K. Witter Foundation, Inc.
Polar Lab Projects Redefines Laboratory Relocation Standards with Global, Single-Source Logistics Solution
Polar Lab Projects is setting a new standard in laboratory relocations and logistics, offering a single-source, seamless solution tailored to the life sciences industry worldwide. With an extensive network of industry experts, they provide unmatched service excellence, meeting clients' needs wherever they operate. - November 06, 2024 - Polar Lab Projects LLC
Synaps Dx Launches Digital Cognitive Screening and Alzheimer’s Testing with BrainCheck and Clarity Health Clinics
Synaps Dx, BrainCheck, and Clarity Health introduce an innovative online Alzheimer's and cognitive health screening tool, accessible from home. Launching in Texas, with nationwide expansion planned, this telehealth solution provides families with a convenient, reliable path to early detection during National Alzheimer’s Disease Awareness Month, reducing the need for in-office visits and empowering proactive cognitive care. - November 04, 2024 - SynapsDx
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
GlycoMira Therapeutics Receives Key Patent for First-in-Class Oncology Therapeutic
Key patent covering GlycoMira's lead compound GM-1111 adds to the Company's already strong IP portfolio. - November 04, 2024 - GlycoMira Therapeutics, Inc.
VitaMist® New Wholesale Purchasing Service
New Wholesale Business Offering is Geared for Distributors and Retailers - November 02, 2024 - VitaMist
VITAMIST® Launches New MultiPlus Multivitamin Oral Spray
Multi-Vitamin Plus Oral Spray is a Comprehensive Blend of Essential Nutrients - November 02, 2024 - VitaMist
Hemanext Signs Agreement with Hemara Bio in the U.A.E., Marking the Initiation of Commercialization Activities in the GCC Region
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announced that it has entered into an exclusive distribution agreement with Hemara Bio in Dubai, United Arab Emirates (UAE) to bolster its sales capabilities across the Gulf Countries strengthening its relationships with key blood centers and clinicians in the region. - October 31, 2024 - Hemanext
NuvOx Announces Two New Publications
Co-Founders, Dr. Evan Unger and Dr. Jennifer LH Johnson combine efforts to publish 2 journal articles that help explain how the NuvOx drug candidate - NanO2TM works. Artificial Cells, Nanomedicine, and Biotechnology published Dodecafluoropentane emulsion as an oxygen therapeutic, an article that... - October 31, 2024 - NuvOx Therapeutics
Novugen Pharma Malaysia Achieves Zero Form 483 Citations in Recent USFDA Audit
Novugen Pharma Sdn. Bhd. proudly announces the successful completion of recent USFDA audit, achieving zero Form 483 citations and No Action Indicated (NAI) status—the highest level of compliance for USFDA-registered manufacturing facilities. This milestone positions Novugen among a select few global companies meeting these standards and reflects the dedication of its team. - October 29, 2024 - Novugen
Knocked Introduces GABA-Powered Sleep Formula – A Natural, Hormone-Free Solution for Restful Nights
Knocked is excited to announce the launch of its latest sleep aid formula, now featuring the calming power of GABA (Gamma-Aminobutyric Acid). This new addition enhances Knocked’s dedication to providing natural, hormone-free sleep solutions, helping users unwind and fall asleep with ease -... - October 26, 2024 - Knocked
EPA Expands TSCA Registration to Full Amphi Biosurfactant Line
Locus FS is now the first US-based company authorized by the EPA to produce biosurfactants at commercial volumes under expanded TSCA registration. This includes the Locus Ingredients division's full line of Amphi sophorolipids, offering formulators USA-made, 100% bio-based alternatives to petrochemical surfactants that can be customized for cleaning, degreasing, and corrosion resistance, while meeting strict regulations. - October 25, 2024 - Locus Performance Ingredients
US EPA Approves Locus FS’ Expanded List of Biosurfactants for the Consumer and Industrial Markets
Locus Fermentation Solutions has become the first and only US-based company authorized by the EPA to produce biosurfactants at commercial volumes under expanded Toxic Substances Control Act (TSCA) registration. This approval positions Locus FS as the leading domestic producer of 100% bio-based glycolipid biosurfactants, providing formulators with scalable, eco-friendly alternatives to chemicals in agriculture, oil & gas, industrial applications, home care, personal care and more. - October 25, 2024 - Locus Fermentation Solutions
Clean-Tech Pioneer Pipper Standard® Awarded Multiple Patents in India
The Equator Group recognized for their Innovative Fruit Fermentation Technology for Natural Cleaning and Softening - October 22, 2024 - Equator Pure Nature Co., Ltd.
Bloom Lab Launches The Menopause Playbook on World Menopause Day
In honour of World Menopause Day, Bloom Lab is launching The Menopause Playbook, a no-nonsense guide for today's forward-thinking woman with everything she needs to know to tackle menopause like a pro without having to sift through endless books, articles or studies. Created by Kristina von... - October 20, 2024 - Bloom Lab
Nebula Scientific Announces Private Label Service
New Private White Label Service for Oral Spray Vitamins and Supplements - October 19, 2024 - VitaMist
Parvus Announces First Human Subject Dosed in a Clinical Trial with PVT201, a First-in-Class Off-the-Shelf Regulatory T-cell (Treg) Inducing pMHC Nanomedicine Therapy
Parvus Therapeutics, a private clinical-stage biopharmaceutical company developing a pipeline of novel treatments for autoimmune disease announced the successful dosing of the first subject in a Phase 1/2, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PVT201 single ascending doses in healthy subjects and primary biliary cholangitis patients. - October 17, 2024 - Parvus Therapeutics U.S., Inc.
Aker BioMarine Launches New Website Dedicated to Krill Oil Science and Education
KrillOil.com, a new consumer website for all things related to krill oil, is launching today. - October 06, 2024 - Aker BioMarine
Award-Winning Cleantech Startup Joins Cummings Properties' Woburn, MA Innovation Cluster
Active Surfaces, an early-stage solar technology company, expanded from Greentown Labs' cleantech incubator in Somerville, MA to a dedicated R&D facility in Cummings Properties' Woburn, MA innovation cluster. - October 05, 2024 - Cummings Properties
October is Havana Syndrome Awareness Month
October is Havana Syndrome Awareness Month. The purpose is to raise awareness about Havana Syndrome injuries caused by directed energy. - October 05, 2024 - Havana Syndrome, Inc.
CCT Sciences, a Global Leader in Cannabinoid Sciences, Announces Launch of Patent Enforcement Across the United States
CCT Sciences, LLC., a global leader in cannabinoid sciences, announces the beginning of patent enforcement across the United States. CCT Sciences (CCT) has been awarded several patents on the manufacturing of Delta 8 THC and Delta 9 THC from industrial hemp-derived cannabidiol (CBD). In addition to... - October 03, 2024 - CCT Sciences
Glucolate Unveils Breakthrough Diabetic Study
Glucolate Unveils Breakthrough Study from University of California, Irvine: New Powder Form Reduces Glucose Absorption in Type 2 Diabetics Glucolate, an innovative leader in diabetes management, is proud to announce groundbreaking findings from a recent study conducted at the University of... - October 02, 2024 - Glucolate Processing, LLC
CURE Pharmaceutical Appoints Raymond Watt to Board of Directors
CURE Pharmaceutical, renowned for its innovative sublingual delivery systems, is proud to announce the appointment of Raymond Watt to its Board of Directors. - October 01, 2024 - CURE Pharmaceutical, Inc.
73-Year-Old Dorothy Erlanger Completes Olympic National Championship Triathlon After Just Four Months of Training
In a remarkable display of determination and resilience, 73-year-old Dorothy Erlanger has successfully completed the USA Triathlon National Championship Olympic triathlon, overcoming significant challenges, including a limb length difference and a decade-long hiatus from training. From Dorothy: “This experience has shown me that with determination and the right mindset, anything is possible. I hope to inspire others to take that first step toward their own goals.” - September 28, 2024 - Erlanger Inc
Exergy Energy Announces Contract to Engineer Chemical Plant Electrification & Decarbonization
A leading chemical manufacturer in upstate New York has contracted with Exergy Energy, the Concierge Utility®, to engineer the electrification and decarbonization of one of their plants to eliminate the use of natural gas. Combining on-site renewable generation, renewable grid power, electric... - September 28, 2024 - Exergy Energy
BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays
BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay... - September 26, 2024 - BUHLMANN Diagnostics Corp
ASI Partnership with New Industry Leaders and Its Products and Service Offering
ASI has been slow in choosing partners and products: at last they have chosen products that are inline with their expertise. These new products such as Microsoft Dynamics and Power Automate, Automation Anywhere, Jira, Confluence, and BitBucket are just a few new tools that we are going to support. - September 23, 2024 - Advanced Software Integration
Canaritech Announces the Launch of Operations, Offering Comprehensive Clinical Trial Solutions Across Latin America
Canaritech, a Contract Research Organization (CRO), has officially launched operations across Latin America, with offices in Mexico, Peru, Chile, and Colombia. The company offers a range of clinical trial services, including regulatory consulting, trial management, decentralized clinical trials, and post-market studies. Canaritech aims to drive innovation in clinical research by improving trial efficiency and increasing patient access through localized expertise and advanced technologies. - September 22, 2024 - Canaritech
NuvOx Pharma LLC Announces Receipt of Qualified Person’s Declaration Equivalence to UK / EU GMP for Investigational Medical Products
NuvOx Pharma LLC, a wholly owned subsidiary of NuvOx Therapeutics Inc. (together, “NuvOx”) announced that it has received a Qualified Person’s Declaration Equivalence to UK / EU GMP for Investigational Medicinal Products Manufactured outside of EU (in Third Countries) . This... - September 21, 2024 - NuvOx Therapeutics
Superior Rail & Iron Works Named First-Ever Diamond Sponsor for ALS TDI’s White Coat Affair Gala
The ALS Therapy Development Institute (ALS TDI) has announced that Superior Rail & Iron Works, Inc. will be the first-ever Diamond Sponsor for the annual White Coat Affair gala, taking place on October 5, 2024, at the Boston Sheraton. Superior Rail & Iron Works, Inc., which was the gala’s Title Sponsor last year, is continuing its support, helping ALS TDI push forward with critical research to find treatments for ALS. - September 19, 2024 - ALS Therapy Development Institute
US Biologic, Inc. and the Agricultural Research Service Announce Breakthrough Oral Alternative to Antibiotics for Poultry
US Biologic, Inc. and the U.S. Department of Agriculture’s Agricultural Research Service (ARS) announce today findings of a new alternative to antibiotics in the face of coccidiosis and antimicrobial resistance, which cost the poultry industry $3.5B in annual losses worldwide and endanger the... - September 17, 2024 - US Biologic, Inc.
Valis Corporation Technology Used in Large Brain Model Project
Using Quantum-Entangled Brain Organoids for Artificial Natural and General Intelligence - September 16, 2024 - Valis Corp
Sama Therapeutics and Quine Biologics Announce Collaboration to Develop Breakthrough Antibody Therapeutics for Neurological Disorders
Sama Therapeutics and Quine Biologics have partnered to develop an innovative therapy for neurological disorders, combining AI-driven platforms and advanced antibody engineering. The collaboration focuses on biologics that precisely target the central nervous system, minimizing side effects. By integrating Sama's generative AI with Quine's antibody design expertise, the project addresses unmet medical needs and advances treatments for conditions like Alzheimer’s and multiple sclerosis. - September 13, 2024 - Quine Biologics, Inc.